← Back
Immucell
ICCC · listed on Nasdaq · worth $98.52 million
$10.36
+1.07% today
Six insider buys in the last year, $140.1K in all. None in the last two weeks.
Green dot = an insider bought◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
6.0M shares
66% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, two insiders bought Immucell stock and none sold.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
President and CEO
Boekhorst Paul Francis Olivier te
Bought $76K on Jun 18 — 8,000 shares at $9.50, 45% of what they now own.
1 of 1 earlier purchase did better than the S&P 500
Director
David Scott Tomsche
Bought $7.8K on Nov 25, 2025 — 1,633 shares at $4.77, held through a trust or family, 35% of what they now own.
1 of 1 earlier purchase did better than the S&P 500
All reports
Every insider trade and SEC report we hold for Immucell.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Jun 22BoughtBoekhorst Paul Francis Olivier teJun 22 · Traded Jun 18 · President and CEO+45%8,000 @ $9.50$76K
Dec 3, 2025BoughtBoekhorst Paul Francis Olivier teDec 3, 2025 · President and CEO+36%3,521 @ $5.04$17.7K
Dec 3, 2025BoughtBoekhorst Paul Francis Olivier teDec 3, 2025 · President and CEO+41%2,556 @ $5.00$12.8K
Dec 3, 2025BoughtBoekhorst Paul Francis Olivier teDec 3, 2025 · Traded Dec 2, 2025 · President and CEO+100%3,708 @ $4.87$18.1K
Nov 28, 2025BoughtDavid Scott TomscheNov 28, 2025 · Traded Nov 25, 2025 · Director+35%via a trust or family1,633 @ $4.77$7.8K
2 more with Pro →